Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $3.01M | $3.55M | $3.30M | $2.96M |
| Revenue growth | — | 18.1% | -7.2% | -10.1% |
| Operating income | $468K | $253K | -$182K | -$4.41M |
| Operating margin | 15.6% | 7.1% | -5.5% | -148.6% |
| Net income | $323K | $386K | -$184K | -$3.68M |
| Net margin | 10.7% | 10.9% | -5.6% | -124.0% |
| EPS (diluted) | $0.03 | $0.04 | -$0.02 | -$0.27 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | $576K | $848K | $89.7K | -$2.03M |
| Capital expenditures | $208K | $148K | $127K | $1.07M |
| Free cash flow | $369K | $700K | -$37.0K | -$3.10M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | — | $646K | $457K | $28.7M |
| Total assets | — | $4.75M | $5.21M | $34.8M |
| Total liabilities | — | $3.50M | $4.14M | $2.04M |
| Long-term debt | — | $785K | $192K | — |
| Shareholders' equity | $861K | $1.25M | $1.07M | $32.7M |
| Retained earnings | — | -$839K | -$1.02M | -$4.70M |
| Shares (wtd avg diluted) | 10.9M | 10.9M | 10.9M | 13.9M |
Every figure is extracted from Aureus Greenway Holdings Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.